Pre-orders for “N-NOSE plus Pancreas”, the world’s first early-stage pancreatic cancer test, are now available.

2022.11.17

We are pleased to announce the commercialization of “N-NOSE plus Pancreas”, the world’s first cancer type specific test, the next generation of the N-NOSE nematode cancer test.

“N-NOSE plus Pancreas”, the world’s first test to detect early-stage pancreatic cancer, is now available for practical use.

→PRESS RELEASE